HbA1c is Absolutely Used for Glucose Monitoring in Diabetes
Yes, HbA1c is the primary tool for monitoring glycemic control in diabetes and should be performed routinely in all people with diabetes at initial assessment and as part of continuing care 1. This is established as the gold standard by major diabetes organizations worldwide 2, 1.
How HbA1c Functions as a Monitoring Tool
HbA1c reflects average blood glucose levels over approximately 2-3 months, making it an indirect but highly reliable measure of long-term glycemic control 1. The test is:
- Strongly linked to diabetes complications through decades of clinical trial data 1
- Standardized and accurate when using NGSP-certified assays 1
- Predictive of long-term outcomes, which is why it remains the gold standard 3
Recommended Testing Frequency
The monitoring schedule should be based on glycemic stability 1:
Every 3 months for patients with:
- Unstable glucose levels
- Intensive care plans
- Those not meeting treatment goals
Twice yearly for patients who:
- Have achieved target glucose ranges
- Are maintaining stable control
Point-of-care HbA1c testing enables immediate treatment adjustments during clinical visits 1.
Critical Limitations and When NOT to Rely on HbA1c Alone
HbA1c has important limitations that clinicians must recognize 1, 4:
Conditions That Interfere with HbA1c Accuracy:
- Hemolytic anemia and other anemias (altered red blood cell turnover)
- Glucose-6-phosphate dehydrogenase deficiency
- Recent blood transfusion
- End-stage kidney disease
- Pregnancy
- Drugs stimulating erythropoiesis
- Sickle cell disease (HbSS) or other homozygous hemoglobin variants—HbA1c cannot be measured at all 1
What HbA1c Does NOT Measure:
- Glycemic variability (day-to-day fluctuations)
- Hypoglycemia episodes
- Real-time glucose levels
Alternative Monitoring When HbA1c is Unreliable
When conditions interfere with HbA1c interpretation, use 1:
- Self-monitoring of blood glucose (SMBG)
- Continuous glucose monitoring (CGM)
- Glycated serum protein assays (fructosamine or glycated albumin)
For patients with type 1 diabetes or type 2 diabetes with high glycemic variability, fructosamine or glycated albumin may be more useful alternatives 1.
The Complementary Role of Daily Glucose Monitoring
HbA1c does not replace daily glucose monitoring—both are essential 2. Patients need:
- HbA1c for long-term control assessment (every 2-3 months)
- SMBG or CGM for day-to-day diabetes management and treatment adjustments 2
The correlation between HbA1c and mean glucose is strong (r = 0.92), allowing estimated average glucose (eAG) to be reported alongside HbA1c results 1. However, eAG and random blood glucose values cannot be used interchangeably 5.
Common Pitfalls to Avoid
- Never rely solely on HbA1c in patients with conditions affecting red blood cell turnover 4
- Don't assume HbA1c captures hypoglycemia—it only reflects average glucose 1
- If clinical presentation and HbA1c are incoherent, suspect spurious results and measure fasting glucose 4
- Most U.S. assays are accurate for heterozygous hemoglobin variants, but homozygous variants make HbA1c unmeasurable 1